Novavax says its COVID-19 vaccine is more than 90 per cent effective
Published
Novavax says late-stage data from its US-based clinical trial shows its vaccine is more than 90 per cent effective against COVID-19.
Full ArticlePublished
Novavax says late-stage data from its US-based clinical trial shows its vaccine is more than 90 per cent effective against COVID-19.
Full ArticleVaccine maker Novavax says its shot is highly effective against Covid-19 and also protected against variants in a large, late-stage..
By Susi Dennison and Jana Puglierin*
*Introduction*
On 4 April 2021, a headline in the Daily Express –..